![Western Blot: MICL/CLEC12A Antibody [NBP2-27346] - Analysis of CLEC12A using CLEC12A antibody. ThP1 cell lysate in the 1) absence and 2) presence of immunizing peptide probed with 2 ug/ml of CLEC12A antibody. I goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/MICL-CLEC12A-Antibody-Western-Blot-NBP2-27346-img0002.jpg "Western Blot: MICL/CLEC12A Antibody [NBP2-27346] - Analysis of CLEC12A using CLEC12A antibody. ThP1 cell lysate in the 1) absence and 2) presence of immunizing peptide probed with 2 ug/ml of CLEC12A antibody. I goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
| Reactivity | Hu, PmSpecies Glossary |
| Applications | WB |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Concentration | 0.5 mg/ml |
| Immunogen | A portion of amino acids170-220 from human CLEC12A was used as the immunogen. |
| Predicted Species | Chimpanzee (94%). Backed by our 100% Guarantee. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | CLEC12A |
| Purity | Protein A purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
|
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS and 0.05% BSA |
| Preservative | 0.05% Sodium Azide |
| Concentration | 0.5 mg/ml |
| Purity | Protein A purified |
| Publication using NBP2-27346 | Applications | Species |
|---|---|---|
| Chiaro TR, Bauer KM, Ost KS et al. Clec12a tempers inflammation while restricting expansion of a colitogenic commensal bioRxiv : the preprint server for biology 2023-03-16 [PMID: 36993296] (WB, Human) | WB | Human |
Secondary Antibodies |
Isotype Controls |
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![CD94 Antibody (131412) [Unconjugated]](/sites/all/modules/enterprise-tech/et_datasheets/images/novus_guarantee.png "CD94 Antibody (131412) [Unconjugated]")
![Bioactivity CTLA-4 [Unconjugated]](https://images.novusbio.com/images2/CTLA4_7268CT_2293.jpg)
![Flow Cytometry NKG2A/CD159a/KLRC1 Antibody (131411) [Unconjugated]](https://images.novusbio.com/images2/NKG2A_MAB1059_Flow_Cytometry_21858.jpg)
![Flow Cytometry NKG2A/CD159a/KLRC1 Antibody (131411) [Unconjugated]](https://images.novusbio.com/images2/NKG2A_MAB1059_Flow_Cytometry_21859.jpg)
![Immunohistochemistry CD34 Antibody [Unconjugated]](https://images.novusbio.com/images2/CD34_AF4117_Immunohistochemistry_6824.jpg)
![N/A SP-D [HRP]](https://images.novusbio.com/images2/SP-D_DSFPD0_ELISA_181.jpg)
![N/A SP-D [HRP]](https://images.novusbio.com/images2/DATA_SPD_DSFPD0_ELISA_825.jpg)
![N/A SP-D [HRP]](https://images.novusbio.com/images2/DATA_SPD_DSFPD0_ELISA_826.jpg)
![Bioactivity IL-2 [Unconjugated]](https://images.novusbio.com/images/202-il_recombinant-human-il-2-protein-bioactivity-174202314946.jpg)
![Agonist Activity KIR2DL4/CD158d Antibody (181703) [Unconjugated]](https://images.novusbio.com/images2/KIR2DL4_MAB2238_Functional_Assay_2107.jpg)
![Flow Cytometry KIR2DL4/CD158d Antibody (181703) [Unconjugated]](https://images.novusbio.com/images2/mab2238_human-kir2dl4-cd158d-mab-clone-181703-flow-cytometry-142021125517.jpg)
![SDS-PAGE TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_210-TA_256.jpg)
![Bioactivity TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNFalpha_210TA_1658.jpg)
![SEC-MALS TNF-alpha [Unconjugated]](https://images.novusbio.com/images/210-ta_recombinant-human-tnf-alpha-protein-sec-mals-35202312244..jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")